Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1594898 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1723884 | Peak area | PAK | Untreated |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1801024 | Peak area | PAK | TNF-alpha |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1913180 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1913934 | Peak area | BS4 | Untreated |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 1942031 | Peak area | PAK | IFN-G |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 2009860 | Peak area | PAK | IL-17A |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 2069744 | Peak area | HAHA | IFN-G |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 2150031 | Peak area | BS4 | IL-17A |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 2176384 | Peak area | HAHA | TNF-alpha |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 2233180 | Peak area | BS4 | TNF-alpha |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 2310525 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 2311399 | Peak area | BS4 | IFN-G |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 2499079 | Peak area | HAHA | IL-17A |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M-H)- | 3191119 | Peak area | HAHA | Untreated |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 381854 | Peak area | PAK | IFN-G |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 414205 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 448426 | Peak area | PAK | IL-17A |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 455401 | Peak area | BS4 | TNF-alpha |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 486772 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 513943 | Peak area | BS4 | IL-17A |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 530267 | Peak area | BS4 | IFN-G |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 535761 | Peak area | HAHA | IL-17A |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 553378 | Peak area | HAHA | IFN-G |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 659446 | Peak area | BS4 | Untreated |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 1168236 | Peak area | PAK | TNF-alpha |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 1293006 | Peak area | PAK | Untreated |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 1298638 | Peak area | HAHA | TNF-alpha |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 1361208 | Peak area | HAHA | Untreated |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+H)+ | 1441738 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 8867 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 12049 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 12766 | Peak area | PAK | IFN-G |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 14574 | Peak area | PAK | IL-17A |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 15229 | Peak area | BS4 | TNF-alpha |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 17648 | Peak area | HAHA | IFN-G |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 17718 | Peak area | HAHA | IL-17A |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 20226 | Peak area | BS4 | IL-17A |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | 21852 | Peak area | BS4 | Untreated |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | Peak area | BS4 | IFN-G | |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | Peak area | HAHA | TNF-alpha | |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | Peak area | HAHA | Untreated | |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | Peak area | PAK | TNF-alpha | |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | Peak area | PAK | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | PHENYLALANINE (CAS# 63-91-2); (M+NA)+ | Peak area | PAK | Untreated |